Analysis of Latissimus Dorsi Flap Reconstructions
Latissimus Dorsi Flap Reconstructions: Retrospective Study
This study looks at how well latissimus dorsi flap surgeries work for patients with large defects and what factors influence the healing and quality of life after the procedure.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna Academic / other |
| Locations | 1 site (Bologna) |
| Trial ID | NCT06800547 on ClinicalTrials.gov |
What this trial studies
This observational study examines the outcomes of latissimus dorsi (LD) flap reconstructions performed at the IRCCS Azienda Ospedaliero-Universitaria di Bologna. It aims to analyze the decision-making process regarding the use of LD harvesting for repairing large defects, correlating these choices with patient healing, quality of life, and complications at both the recipient and donor sites. The study will review historical data to identify patterns and outcomes associated with LD flap procedures, focusing on surgery duration, hospitalization, reoperation rates, and patient survival. The findings may help establish guidelines for when LD harvesting is advisable or contraindicated.
Who should consider this trial
Good fit: Ideal candidates for this study are patients who have undergone latissimus dorsi flap reconstructions for large defects.
Not a fit: Patients with incomplete or missing data regarding their surgical outcomes will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved guidelines for the use of latissimus dorsi flaps, enhancing patient outcomes and quality of life.
How similar studies have performed: While there may be studies on flap reconstructions, this specific analysis of LD flap outcomes is relatively novel and aims to fill a gap in established guidelines.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Duration of surgery, expressed in minutes; * Hospitalization time, expressed in days; * Need for reoperation within 30 days of the first operation; * Survival and recurrences, based on the last available follow-up Exclusion Criteria: * Incomplete or missing data
Where this trial is running
Bologna
- IRCCS AOU di Bologna Policlinico di Sant'Orsola — Bologna, Italy (Recruiting)
Study contacts
- Principal investigator: Marco Pignatti, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Study coordinator: Marco Pignatti, MD
- Email: marco.pignatti@unibo.it
- Phone: +390512143614
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.